Curbing circulation of spurious and substandard medicines with QR codes
Nakul Pasricha, President, ASPA, explains the need for QR codes in curbing the circulation of spurious and substandard medicines…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Zeon Lifesciences signs MoU with NIPER to establish academic interaction and research advancement
The objective of this collaboration is to carry out R&D projects to examine the product formulation and its development in the…
Zydus receives final approval from US FDA for Empagliflozin and Metformin Hydrochloride Tablets
Empagliflozin and Metformin Hydrochloride tablets are used with proper diet and exercise to improve glycemic control in adults…
Maximize the return on your Agilent instrument investments
Maximizing instrument utilization and throughput are high priorities for most labs. But insufficient training and inexperienced…
Data visualisation and exploration for pharma applications using JMP®
JMP provides all the tools needed to make breakthrough discoveries from data and convey results
Indian Immunologicals to expand operations in New Zealand
Indian Immunologicals's subsidiary inaugurated a new facility for the production of sterile-filtered serum
Pharma leaders network at PHARMAP 2022
The two-day business programme included networking and interaction among representatives of the pharma industry, panel…
Government moots regulation of medical devices and e-pharmacies
Also, for the first time, regulations for conduct of clinical trials for new drugs and medical devices have been brought under the…
Lupin’s Somerset manufacturing plant receives EIR from US FDA
FDA changes inspection classification of Somerset facility to Voluntary Action Indicated (VAI)
Pharma industry reports 61 deals worth $6.4 billion in June 2022, says GlobalData
The industry reported 115 Venture Capital (VC) deals worth $3.7 billion in June 2022, compared to the last 12-month average (June…